Pharmaceutical Attorneys Dangerous Drugs Defective Medical Devices Medical Conditions Currently Accepted Cases Our Lawyers Do I Have a Case? Contact Us

Pfizer Settles Pristiq Lawsuit for $67 Million

Drug manufacturing giant Pfizer Inc has settled a class-action lawsuit with shareholders who were misled about risks associated with the antidepressant Pristiq. The cost to Pfizer will be a whopping $67.5 million.

The all-cash settlement was made public on November 9, one month after Pfizer settled a different lawsuit accusing the company of misleading investors about clinical trial results for the arthritis drug Celebrex; that settlement totaled $164 million.

The Pristiq lawsuit revolves around a large drop in the stock value of Wyeth shares (the company was acquired by Pfizer in 2009) that occurred on July 24, 2007. The drop, which caused a loss of over $7 billion of share value, was a result of the Food and Drug Administration’s refusal to approve Pristiq to treat "hot flashes" in post-menopausal women because of potential heart and liver problems associated with the drug.

Shareholders claim that Wyeth concealed these adverse side effects, knowingly allowing stock prices to be inflated between June 26, 2006 and July 24, 2007.

The settlement comes after almost six months of mediation. It is awaiting approval by U.S. District Judge Richard Sullivan in Manhattan.

Categories: Dangerous Drugs

Comments

No Comments Posted
Accutane Settlement Upheld in Court
In 2008, Karnie Kendall was awarded $10.5 million dollars by a jury, after her attorneys proved that Accutane, a medication she took to treat acne, ha... Read More [+]
Covidien Brain Device Tied to Nine Deaths Since 2005
Defects in Covidien Inc.'s Onyx Liquid Embolic System have been linked to nine patient deaths and at least 100 injuries since 2005, the Food and D... Read More [+]
Heartburn Drugs Increase Hip Fractures in Smokers
Popular Proton Pump Inhibitors (PPIs), used to treat heartburn, acid reflux, and ulcers, were found to increase the risk of hip fractures in women smo... Read More [+]